NASDAQ:BGLC BioNexus Gene Lab (BGLC) Stock Price, News & Analysis → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free BGLC Stock Alerts $0.52 0.00 (0.00%) (As of 05/28/2024 ET) Add Compare Share Share Today's Range$0.52▼$0.5550-Day Range$0.52▼$0.8552-Week Range$0.31▼$17.88Volume30,826 shsAverage Volume981,683 shsMarket Capitalization$9.19 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get BioNexus Gene Lab alerts: Email Address Ad Chaikin AnalyticsWall Street Legend Warns: "A Strange Day Is Coming to America"Get Your Cash Out of U.S. Banks Immediately Man who predicted 2023 bank run warns a historic financial reset is coming. Get out of cash and into a new vehicle 50 years in the making.Click here to learn more. About BioNexus Gene Lab Stock (NASDAQ:BGLC)BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.Read More BGLC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BGLC Stock News HeadlinesApril 19, 2024 | msn.comWhy Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day SessionApril 19, 2024 | investorplace.comWhy Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?April 18, 2024 | marketwatch.comBioNexus Gene Lab Invests in AI Healthcare CompanyApril 18, 2024 | globenewswire.comBioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in HealthcareFebruary 22, 2024 | benzinga.comBioNexus Gene Lab Stock (NASDAQ:BGLC), Short Interest ReportFebruary 22, 2024 | benzinga.comBioNexus Gene Lab Stock (NASDAQ:BGLC), Analyst Ratings, Price Targets, PredictionsFebruary 14, 2024 | finance.yahoo.comCompanies Like BioNexus Gene Lab (NASDAQ:BGLC) Can Afford To Invest In GrowthDecember 20, 2023 | nasdaq.comBioNexus Gene Lab Corp Common stock (BGLC)November 22, 2023 | seekingalpha.comBGLC BioNexus Gene Lab Corp.October 16, 2023 | sg.finance.yahoo.comBioNexus Gene Lab Corp. (BGLC)August 23, 2023 | markets.businessinsider.comWhy Is BioNexus Gene Lab (BGLC) Stock Up 33% Today?July 28, 2023 | investing.comBioNexus Gene Lab Corp (BGLC)July 24, 2023 | seekingalpha.comIPO Roundup: Surf Air Mobility, Opti-Harvest and moreJuly 24, 2023 | finanznachrichten.deBIONEXUS GENE LAB CORPJuly 24, 2023 | finance.yahoo.comBioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital MarketJuly 21, 2023 | morningstar.comBioNexus Gene Lab Corp Ordinary SharesJuly 21, 2023 | msn.comInvestors Look to Close Week on Positive Note as US Futures See Mixed Performance Premarket FridayJuly 21, 2023 | investorplace.comWhy Is BioNexus Gene Lab (BGLC) Stock Up 64% Today?July 20, 2023 | finance.yahoo.comBioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital MarketJuly 19, 2023 | finance.yahoo.comBGLC - BioNexus Gene Lab Corp.July 19, 2023 | wsj.comBioNexus Gene Lab Corp.See More Headlines Receive BGLC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioNexus Gene Lab and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/28/2024Next Earnings (Estimated)8/21/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:BGLC CUSIPN/A CIK1737523 Webwww.bionexusgenelab.com Phone60-1-2212-6512FaxN/AEmployees30Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,630,000.00 Net Margins-27.24% Pretax Margin-26.99% Return on Equity-30.74% Return on Assets-25.41% Debt Debt-to-Equity RatioN/A Current Ratio4.60 Quick Ratio3.98 Sales & Book Value Annual Sales$9.77 million Price / Sales0.95 Cash FlowN/A Price / Cash FlowN/A Book Value$0.55 per share Price / Book0.96Miscellaneous Outstanding Shares17,670,000Free Float16,460,000Market Cap$9.30 million OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Su-Leng Tan (Age 40)CEO, Acting CFO, Secretary & Director Comp: $16kMr. Kwan Wah ChanMarketing ManagerMr. Too Kam ThamManaging DirectorKey CompetitorsRenalytixNASDAQ:RNLXExagenNASDAQ:XGNDermTechNASDAQ:DMTKOpGenNASDAQ:OPGNFresh2 GroupNASDAQ:FRESView All CompetitorsInstitutional OwnershipVirtu Financial LLCBought 20,888 shares on 5/20/2024Ownership: 0.266%View All Institutional Transactions BGLC Stock Analysis - Frequently Asked Questions How have BGLC shares performed in 2024? BioNexus Gene Lab's stock was trading at $0.53 at the beginning of the year. Since then, BGLC stock has decreased by 1.9% and is now trading at $0.5199. View the best growth stocks for 2024 here. Are investors shorting BioNexus Gene Lab? BioNexus Gene Lab saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 105,900 shares, a drop of 40.0% from the April 30th total of 176,500 shares. Based on an average daily volume of 218,100 shares, the short-interest ratio is presently 0.5 days. Currently, 1.3% of the shares of the company are sold short. View BioNexus Gene Lab's Short Interest. When is BioNexus Gene Lab's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 21st 2024. View our BGLC earnings forecast. When did BioNexus Gene Lab IPO? BioNexus Gene Lab (BGLC) raised $5 million in an initial public offering on Thursday, July 20th 2023. The company issued 1,300,000 shares at a price of $4.00 per share. Network 1 Financial Securities served as the underwriter for the IPO. Who are BioNexus Gene Lab's major shareholders? BioNexus Gene Lab's stock is owned by many different institutional and retail investors. Top institutional investors include Virtu Financial LLC (0.27%). How do I buy shares of BioNexus Gene Lab? Shares of BGLC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BGLC) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsBitcoin’s Biggest Year YetParadigm PressThe #1 Crypto for AIWeiss RatingsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.